The Human Placenta is a Hematopoietic Organ During the Embryonic and Fetal Periods of Development

Overview

Journal Dev Biol

Publisher Elsevier

Specialties Biology
Reproductive Medicine

Date 2008 Dec 17

PMID 19073167

Citations 16

Authors

Alicia Barcena

Mirhan Kapidzic

Marcus O Muench

Matthew Gormley

Marvin A Scott

Jingly F Weier

Christy Ferlatte

Susan J Fisher

Affiliations

Soon will be listed here.

Abstract

We studied the potential role of the human placenta as a hematopoietic organ during embryonic and fetal development. Placental samples contained two cell populations-CD34(++)CD45(low) and CD34(+)CD45(low)-that were found in chorionic villi and in the chorioamniotic membrane. CD34(++)CD45(low) cells express many cell surface antigens found on multipotent primitive hematopoietic progenitors and hematopoietic stem cells. CD34(++)CD45(low) cells contained colony-forming units culture (CFU-C) with myeloid and erythroid potential in clonogenic in vitro assays, and they generated CD56(+) natural killer cells and CD19(+)CD20(+)sIgM(+) B cells in polyclonal liquid cultures. CD34(+)CD45(low) cells mostly comprised erythroid- and myeloid-committed progenitors, while CD34(-) cells lacked CFU-C. The placenta-derived precursors were fetal in origin, as demonstrated by FISH using repeat-sequence chromosome-specific probes for X and Y. The number of CD34(++)CD45(low) cells increased with gestational age, but their density (cells per gram of tissue) peaked at 5-8 wk, decreasing more than sevenfold at the onset of the fetal phase (9 wk of gestation). In addition to multipotent progenitors, the placenta contained myeloid- and erythroid-committed progenitors indicative of active in situ hematopoiesis. These data suggest that the human placenta is an important hematopoietic organ, raising the possibility of banking placental hematopoietic stem cells along with cord blood for transplantation.

Citing Articles

Current Status of Biomedical Products for Gene and Cell Therapy of Recessive Dystrophic Epidermolysis Bullosa.

Zorina A, Zorin V, Isaev A, Kudlay D, Manturova N, Ustugov A Int J Mol Sci. 2024; 25(19).

PMID: 39408598 PMC: 11476579. DOI: 10.3390/ijms251910270.

The Fetal-to-Adult Hematopoietic Stem Cell Transition and its Role in Childhood Hematopoietic Malignancies.

Mack R, Zhang L, Breslin Sj P, Zhang J Stem Cell Rev Rep. 2021; 17(6):2059-2080.

PMID: 34424480 PMC: 9059172. DOI: 10.1007/s12015-021-10230-x.

Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.

Liao Y, Ivanova L, Sivalenka R, Plumer T, Zhu H, Zhang X Stem Cells Transl Med. 2018; 7(7):530-542.

PMID: 29745997 PMC: 6052609. DOI: 10.1002/sctm.17-0182.

Cellular kinetics of perivascular MSC precursors.

Chen W, Park T, Murray I, Zimmerlin L, Lazzari L, Huard J Stem Cells Int. 2013; 2013:983059.

PMID: 24023546 PMC: 3760099. DOI: 10.1155/2013/983059.

Landscape of transcriptional deregulations in the preeclamptic placenta.

Vaiman D, Calicchio R, Miralles F PLoS One. 2013; 8(6):e65498.

PMID: 23785430 PMC: 3681798. DOI: 10.1371/journal.pone.0065498.

References

Rhodes K, Gekas C, Wang Y, Lux C, Francis C, Chan D . The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell. 2008; 2(3):252-63. PMC: 2888040. DOI: 10.1016/j.stem.2008.01.001. View

Challier J, Carbillon L, Kacemi A, Vervelle C, Bintein T, GALTIER M . Characterization of first trimester human fetal placental vessels using immunocytochemical markers. Cell Mol Biol (Noisy-le-grand). 2002; 47 Online Pub:OL79-87. View

Miki T, Lehmann T, Cai H, Stolz D, Strom S . Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005; 23(10):1549-59. DOI: 10.1634/stemcells.2004-0357. View

Gekas C, Dieterlen-Lievre F, Orkin S, Mikkola H . The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005; 8(3):365-75. DOI: 10.1016/j.devcel.2004.12.016. View

Barcena A, Park S, Banapour B, Muench M, Mechetner E . Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood. 1996; 88(6):2013-25. View

Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L . A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 1993; 81(11):2916-24. View

Linju Yen B, Huang H, Chien C, Jui H, Ko B, Yao M . Isolation of multipotent cells from human term placenta. Stem Cells. 2004; 23(1):3-9. DOI: 10.1634/stemcells.2004-0098. View

Imai K, Maeda M, Fujiwara H, Okamoto N, Kariya M, Emi N . Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase. Biol Reprod. 1992; 46(3):328-34. DOI: 10.1095/biolreprod46.3.328. View

Deaglio S, Mehta K, Malavasi F . Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res. 2001; 25(1):1-12. DOI: 10.1016/s0145-2126(00)00093-x. View

10.

Muench M, Barcena A . Broad distribution of colony-forming cells with erythroid, myeloid, dendritic cell, and NK cell potential among CD34(++) fetal liver cells. J Immunol. 2001; 167(9):4902-9. DOI: 10.4049/jimmunol.167.9.4902. View

11.

Fisher S, Cui T, Zhang L, Hartman L, Grahl K, Zhang G . Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol. 1989; 109(2):891-902. PMC: 2115717. DOI: 10.1083/jcb.109.2.891. View

12.

Tavian M, Coulombel L, Luton D, Clemente H, Dieterlen-Lievre F, Peault B . Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood. 1996; 87(1):67-72. View

13.

Zeigler B, Sugiyama D, Chen M, Guo Y, Downs K, Speck N . The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development. 2006; 133(21):4183-92. DOI: 10.1242/dev.02596. View

14.

Muench M, Cupp J, Polakoff J, Roncarolo M . Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential. Blood. 1994; 83(11):3170-81. View

15.

Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, Uchiyama T . Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol. 1989; 17(2):145-53. View

16.

Barcena A, Muench M, Song K, Ohkubo T, Harrison M . Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells. Exp Hematol. 1999; 27(9):1428-39. DOI: 10.1016/s0301-472x(99)00080-6. View

17.

Melchers F . Murine embryonic B lymphocyte development in the placenta. Nature. 1979; 277(5693):219-21. DOI: 10.1038/277219a0. View

18.

Barcena A, Muench M, Galy A, Cupp J, Roncarolo M, Phillips J . Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloid-cell development. Blood. 1993; 82(11):3401-14. View

19.

Prakobphol A, Genbacev O, Gormley M, Kapidzic M, Fisher S . A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta. Dev Biol. 2006; 298(1):107-17. DOI: 10.1016/j.ydbio.2006.06.020. View

20.

Quadro L, Hamberger L, Gottesman M, Colantuoni V, Ramakrishnan R, Blaner W . Transplacental delivery of retinoid: the role of retinol-binding protein and lipoprotein retinyl ester. Am J Physiol Endocrinol Metab. 2004; 286(5):E844-51. DOI: 10.1152/ajpendo.00556.2003. View